It is given as a tablet containing 2 mg of dienogest and 30 μ G of ethinylestradiol.

Substances diminishing the efficacy of COCs: Dienogest is a substrate of CYP3A4.

Diabetes: As with other progestins, dienogest may cause changes in blood glucose control.

It is given as a tablet containing 2 mg of dienogest and 30 μg of ethinylestradiol.

The medication cannot be used in the girls who have not yet had their first menstrual period.

The treatment and/or prevention of depression by the co-administration of an estrogen with the progestin dienogest for HR and/or contraception.

It is not meant for use by men or girls who have not yet had their first menstrual period.

Dienogest belongs to the class of medications called progestins, medications that act like progesterones (female hormones) in the body.

Children: This medication is not intended to be used by girls who have not yet had their first menstrual period.

Dienogest belongs to the class of medications called progestins, medications that act like progesterones in the body.

Progestin preparations (corpus luteum hormones) such as dienogest or dydrogesterone can also relieve endometriosis pain.

A relatively high fraction (10%) of circulating dienogest is present in the free form, with approximately 90% being bound non-specifically to albumin.

Blood clots: Dienogest may increase the risk of developing blood clots in the lungs and legs.

Each coloured active tablet contains a small amount of female hormones, either estradiol valerate, or estradiol valerate combined with dienogest.

It has some antiandrogenic activity in addition to its progestogenic effects and as a result may improve symptoms of androgen-dependent conditions like acne.